This project, delivered for VIDO-Intervac at the University of Saskatchewan’s Innovation Place, involved the development of a GMP-ready production facility at VIDO-Intervac for the manufacture of vaccines for human and animal clinical trial (mammalian and bacterial).
The GMP production Facility is designed to utilize single use systems that maximize the flexibility of production and leverages existing containment Infrastructure at VIDO-InterVac. The GMP production facility is planned as a renovation to existing shell space at InterVac as well as adjacent work areas (for support functions) on the main and second floors.
Consideration was given to renovating the space with clean room modular panel installations as well as as well as traditional ‘stick’ built methods. The project was designed as a non-GMP suite initially, which will be upgraded to GMP in the future. Live viruses and live cells will be handled in both non-GMP and GMP stages (Risk Group 2).